Filing Details
- Accession Number:
- 0001209191-18-063586
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2018-12-19 19:57:44
- Reporting Period:
- 2018-12-17
- Accepted Time:
- 2018-12-19 19:57:44
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1513818 | Aravive Inc. | ARAV | Pharmaceutical Preparations (2834) | 264106690 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1723780 | Kevin Haas | C/O Aravive, Inc. Lyondellbassell Tower, 1221 Mckinney St. Houston TX 77010 | Vp, Finance And Pao | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2018-12-17 | 1,164 | $3.96 | 11,848 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct |
Footnotes
- Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of certain RSUs, previously reported in Table I following the date of grant.
- The number of shares reflects the one-for-six reverse stock split effected by Aravive, Inc. on October 16, 2018.
Billionaire Hedge Funds
